The advertisement promotes NUBEQA® (darolutamide) and addresses concerns regarding rising PSA levels while on ADT (androgen deprivation therapy).
Creative Information
| CID: | 8ac15448-a802-46c6-8cb1-2e582192100b |
| CRID: | 82_1075-793622 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 160x600 |
| Bid: | $2.03 |
| Timestamp: | 10/30/2025, 4:11:00 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/30/2025, 5:09:06 PM | 6.91s | |
| adomain_analysis | success | 10/30/2025, 5:18:26 PM | 4.34s | |
| adomain_capture | success | 10/30/2025, 5:18:22 PM | 0.10s | |
| ad_render | success | 10/30/2025, 5:08:59 PM | 25.15s | |
| brand_mapping | success | 10/30/2025, 4:11:01 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1231.09 KB | ||||||||||||||||||||||
| Render Time: | 9.40 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1231.13 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


